COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2021.01.29.21250749: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementIRB: The Institutional Review Board at the College of Medicine and King Saud University Medical City approved the study (approval #20/0065/IRB).
    Consent: A waiver for signed consent was obtained since the survey presented no more than a minimal risk to subjects and involved no procedures for which written consent is usually required.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    No key resources detected.


    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    4.1 Study limitations and strengths/future potential: This study is subject to the limitations of cross-sectional surveys, including sampling, response, and recall biases. While this work did not explore the reasons why HCWs did not register for the vaccine, it presents their initial vaccination acceptance, which needs to be explored in future studies. It should be noted that HCWs’ perceptions and vaccine hesitancy may differ from one country to another. 4.2 Conclusion: This study observed a low level of COVID-19 vaccine enrollment among HCWs during the first month of the vaccine rollout in one of the first countries to roll out the vaccine. Public health officials should scale up their efforts to increase vaccine acceptance and uptake among HCWs to match the speed of the growing pandemic. Optimizing protection of HCWs through vaccination and encouraging them to subsequently recommend vaccination to their patients is vital to curbing this global crisis.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.